Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
124.70Prev. Close
124.84Volume
30,074Total traded value
0.38 CrUpper Circuit
151.45Lower Circuit
100.96Fundamentals
| Market Cap | ₹1,163Cr |
| ROE | 7.41% |
| P/E Ratio(TTM) | -127.68 |
| EPS(TTM) | -0.99 |
| P/B Ratio | 3.15 |
| Dividend Yield | 0.40% |
| Industry P/E | 35.18 |
| Book Value | 40.16 |
| Debt to Equity | 0.21 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Themis Medicare
Themis Medicare is a pharmaceutical company engaged in manufacturing formulations and Active Pharmaceutical Ingredients (APIs). Throughout the year, the company upheld the highest standards of integrity, transparency, and ethical conduct in all its business operations. Demonstrating its commitment to global growth, it has filed more than 75 product registration dossiers for formulations in international markets.;
| Parent Organisation | Themis Medicare |
| Managing Director | Dr. Sachin Patel |
| NSE Symbol | THEMISMED |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 104.62 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.68 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 34.29 | ||
| Wockhardt | NA (0.00%) | -149.63 |